申请人:The Regents of the University of California
公开号:US09422275B2
公开(公告)日:2016-08-23
Certain embodiments of the present invention provide selected compounds having a molecular structure according to Formula 1:
In Formula 1, Z is —CO—, —SO—, or —SO2—; Ar is phenyl, heteroaryl, or heterocycloalkyl; Het is heteroaryl; R is R″, X, or NR1R2; R′ is R3, or OR3; R″ is R4, or OR4; R1 and R2 are each independently H, alkyl, or acyl; R3 is H, heteroaryl, or alkyl; R4 is H, heteroaryl, or CnH2n+1 (n>2); and X is F, Br, I, CN, or NO2. In some embodiments, compounds having a molecular structure according to Formula 1 have the property of inhibiting a growth of a cell line selected from HeLa and MB468 with a sub-micromolar IC50.
本发明的某些实施例提供了具有分子结构式1的选择性化合物:在式1中,Z是—CO—,—SO—或—SO2—; Ar是苯基,杂环芳基或杂环烷基; Het是杂环芳基; R是R″,X或NR1R2; R'是R3或OR3; R″是R4或OR4; R1和R2各自独立地是H,烷基或酰基; R3是H,杂环芳基或烷基; R4是H,杂环芳基或CnH2n + 1(n> 2); X是F,Br,I,CN或NO2。在某些实施例中,具有分子结构式1的化合物具有抑制从HeLa和MB468中选择的细胞系的生长的性质,其IC50为亚微米。